Company intelligence / Profile preview
Chongqing Hilan Pharmaceutical
Chongqing, Chongqing, Chinacnverify.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Chongqing Hilan Pharmaceutical has a pipeline focused on herbal medicines for nervous system, immune, infectious, and skin/musculoskeletal disorders. At least one product is approved for urticaria; others are in late-stage clinical trials. The company is active with ongoing R&D and manufacturing operations as of mid-2025[1].
- Therapeutic areas
- DermatologyImmunologyNeurologyInfectious Diseases
- Modalities
- Herbal medicine
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Chongqing Hilan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chongqing Hilan Pharmaceutical.